Foreign organizations, individuals and institutions established or actually controlled by them (i.e. foreign units) shall not collect or preserve China human genetic resources.
Suggested Reading
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation? GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests… What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can… Do all medical devices require chemical characterization? How should the evaluation of new items in the endpoint table be considered after the implementation of the new… GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which… When combining subchronic and implantation tests in one project, what factors need to be considered, and how can… Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,… What factors may affect biocompatibility risk when using biological test data from similar devices for… Why is the extraction period typically 24 hours in China for cytotoxicity testing? For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation… How is the endotoxin limit for wound dressing products determined?